Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells

Androgen deprivation therapy is initially effective for treating patients with advanced prostate cancer; however, the prostate cancer gradually becomes resistant to androgen deprivation therapy, which is termed castration‐resistant prostate cancer (CRPC). Androgen receptor splice variant 7 (AR‐V7),...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Sci
Päätekijät: Kita, Kazuaki, Shiota, Masayuki, Tanaka, Masako, Otsuka, Asuka, Matsumoto, Masaki, Kato, Minoru, Tamada, Satoshi, Iwao, Hiroshi, Miura, Katsuyuki, Nakatani, Tatsuya, Tomita, Shuhei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581527/
https://ncbi.nlm.nih.gov/pubmed/28691182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13318
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia